DanCann Pharma A/S is a biopharmaceutical company, which engages in the business of discovering, developing, manufacturing, and commercializing new therapeutic cannabinoids in various disease areas. It operates under the Biomaterials and Import and Export of Medical Cannabis Products segments. The company was founded by Jeppe Krog Rasmussen on March 20, 2018 and is headquartered in Ansager, Denmark.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company